Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin vs Glyburide in Gestational Diabetes
NCT06589141Not yet recruiting
- Sponsor
- Assiut University
- Start
- Jan 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of liquid metformin (Aspargo Labs) and glibenclamide in gestational diabetes mellitus (GDM) (2 arms), sponsored by Assiut University. Primary endpoint: Treatment failure. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
liquid metformin (Aspargo Labs)glibenclamide
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT06589141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06589141.